[1] 刘玉龙, 孙燕, 张明霞, 等. 我国药品不良反应监测发展现状与展望[J]. 中国药业, 2019,28(4): 76-79. [2] Westbrook JI,Li L,Lehnbom EC,et al.What are incident reports telling us?A comparative study at tow Australian hospitals of medication errors identified at audit,detected by staff and reported to an incident system[J]. Int J Qual Heatlth Care,2015,27(1):1-9. [3] 杜国顺. 我国药品不良反应监测工作中存在的问题及对策浅述[J].科技风, 2018(4): 183. [4] 国家药品监督管理局.中华人民共和国药品管理法[EB/OL].(2019-08-26)[2019-08-27].http://www.nmpa.gov.cn/WS04/CL2076/357712.html. [5] 朱磊, 黄萍,李颖. 我国药品不良反应监测发展现状及存在问题[J].中国药事, 2016,30(7): 729-733. [6] Harmark L,van Hunsel F,Grundmark B.ADR reporting by the general public:lessons learnmt from the Dutch and Swedish systems[J].Drug safety,2015,38(4):337-347. [7] 吴世福,王玲,李玉基,等. 我国药品不良反应公众报告模式研究[J]. 中国药物警戒, 2017,14(7):407-412. [8] 王成岗,王东芳,许莉莉,等. 我国药品不良反应公众报告的需求调研及思考[J]. 中国药物警戒, 2017,14(7):402-406. [9] Ting KN,Stratton-Powell DM,Anderson C.Community pharma-cists' views on adverse drug reactions reporting in Malaysia:a pilot study[J].International Journal of Clinical Pharmacy,2010,32(3):339-342. [10] Hazell L,Cornelius V,Hannaford P,et al.How do patients contributeto signal detection?:a retrospective analysis of spontaneous repor-ting of adverse drug reactions in the UK’s Yellow Card Scheme[J].Drug Saf,2013,36(3):199. |